Next-generation ICDs: Individualised Selection for Improved Cardiac Outcomes.

Area of Science:

• Cardiology
• Biomedical Engineering
• Public Health

Background:

• Cardiovascular disease causes significant global mortality, with sudden cardiac death (SCD) often resulting from ventricular tachyarrhythmias.
• High incidence of out-of-hospital cardiac arrests in the UK and low survival rates highlight the need for effective interventions.
• Arrhythmia recurrence rates remain substantial, underscoring the importance of advanced preventative strategies.

Purpose of the Study:

• To review the evolution and current landscape of implantable cardioverter-defibrillators (ICDs) for managing cardiac arrhythmias.
• To discuss the individualized selection criteria for different ICD systems.
• To highlight emerging technologies in cardiac rhythm management.

Main Methods:

• Review of existing literature on ICDs, their technological advancements, and clinical applications.
• Analysis of current trends in device design, implantation techniques, and arrhythmia detection algorithms.
• Examination of patient-specific factors influencing device choice.

Main Results:

• Transvenous single-chamber ICDs are standard, with dual-chamber and CRT devices for specific patient needs.
• Subcutaneous and extravascular ICDs offer alternatives, mitigating lead-related complications.
• Personalized device selection is paramount, considering patient profiles and preferences.

Conclusions:

• ICDs have significantly advanced in preventing sudden cardiac death, with continuous innovation driving personalized strategies.
• The choice of ICD system requires careful consideration of individual patient characteristics and clinical context.
• Future advancements, including leadless pacing, promise further optimization of arrhythmia management.